Supreme Court looks to rein in top patent court with two new cases

A few months ago, the US Supreme Court said it would take up a controversial and divided case regarding software patents. Now, the high court has agreed to take up two more patent cases—both of which could potentially overturn current rules that many in the tech sector see as too lenient for patent owners.

The first case involves a years-long battle between two competitors in the business of creating Content Delivery Networks, or CDNs: Akamai Technologies and Limelight Networks. CDNs are the Internet infrastructure that allows websites to quickly perform “load balancing” and quickly respond to high demand for their content.

The other case regards medical devices, not the Internet. That case, brought by Biosig Instruments against competitor Nautilus Inc., involves a patent that passed legal muster, even though it hinged on an undefined “spaced relationship” between two electrodes. That made it a poster-child for vague patents; frequent patent defendants including Google, Amazon, Newegg, JC Penney, NetApp, SAP America, and Limelight all urged the Supreme Court to take the case.

Read 22 remaining paragraphs | Comments

via Ars Technica


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s